Table 2.
Correlation between the prevalence of the R501X mutation and AD development
R501X | Control group | Studied group | OR* | P-value | ||
---|---|---|---|---|---|---|
1 | 2 | 1–2 | ||||
N | % | N | % | |||
Total | 61 | 100.0 | 60 | 100.0 | 5.56 | 0.0706 |
Normal genotype | 61 | 100.0 | 55 | 91.6 | ||
Heterozygotes | 0 | 0.0 | 4 | 6.6 | ||
Homozygotes | 0 | 0.0 | 1 | 1.6 |